Related Experiment Video
Updated: Oct 20, 2025

Label-Free Imaging of Lipid Storage Dynamics in Caenorhabditis elegans using Stimulated Raman Scattering Microscopy
Published on: May 28, 2021
End-of-life targeted degradation of DAF-2 insulin/IGF-1 receptor promotes longevity free from growth-related
Richard Venz1, Tina Pekec2,3, Iskra Katic3
1Eidgenössische Technische Hochschule Zürich, Department of Health Sciences and Technology, Institute of Translational Medicine, Schwerzenbach-Zürich, Switzerland.
Abstract:
Preferably, lifespan-extending therapies should work when applied late in life without causing undesired pathologies. Reducing insulin/insulin-like growth factor (IGF)-1 signaling (IIS) increases lifespan across species, but the effects of reduced IIS interventions in extreme geriatric ages remains unknown. Using the nematode Caenorhabditis elegans, we engineered the conditional depletion of the DAF-2/insulin/IGF-1 transmembrane receptor using an auxin-inducible degradation (AID) system. This allowed for the temporal and spatial reduction in DAF-2 protein levels at time points after which interventions such as RNAi become ineffective. Using this system, we found that AID-mediated depletion of DAF-2 protein surpasses the longevity of daf-2 mutants. Depletion of DAF-2 during early adulthood resulted in multiple adverse phenotypes, including growth retardation, germline shrinkage, egg retention, and reduced brood size. By contrast, AID-mediated depletion of DAF-2 post-reproduction, or specifically in the intestine in early adulthood, resulted in an extension of lifespan without these deleterious effects. Strikingly, at geriatric ages, when 75% of the population had died, AID-mediated depletion of DAF-2 protein resulted in a doubling in lifespan. Thus, we provide a proof-of-concept that even close to the end of an individual's lifespan, it is possible to slow aging and promote longevity.
Insights
Targeting insulin/IGF-1 signaling late in life can extend lifespan without negative effects. This study shows that reducing DAF-2 protein in old worms can double their remaining lifespan, offering a new aging intervention strategy.
Area of Science:
- Gerontology
- Molecular Biology
- Genetics
Background:
- Reducing insulin/insulin-like growth factor (IGF)-1 signaling (IIS) is a known lifespan-extending strategy across species.
- The efficacy of IIS interventions late in life and their potential pathologies remain largely unexplored.
Purpose of the Study:
- To investigate the effects of late-life interventions targeting IIS on lifespan and healthspan.
- To develop a method for temporal and spatial control of IIS in aging organisms.
Main Methods:
- Engineered a conditional depletion system (auxin-inducible degradation - AID) for the DAF-2 receptor in *Caenorhabditis elegans*.
- Applied DAF-2 depletion at various life stages, including late adulthood and geriatric ages.
- Assessed lifespan extension and adverse phenotypes associated with DAF-2 depletion.
Main Results:
- AID-mediated DAF-2 depletion extended lifespan beyond that of existing *daf-2* mutants.
- Early adulthood DAF-2 depletion caused adverse effects (growth retardation, reduced fertility).
- Late-life or intestine-specific DAF-2 depletion extended lifespan without pathologies.
- Geriatric DAF-2 depletion doubled the lifespan of aged worms.
Conclusions:
- Temporal and spatial control of IIS is crucial for effective lifespan extension without detrimental side effects.
- Late-life interventions targeting IIS, even near the end of lifespan, can significantly slow aging.
- This study provides a proof-of-concept for developing late-life aging interventions.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Replicative Cell Senescence
Insulin: The Receptor and Signaling Pathways
Abnormal Proliferation
The Extrinsic Apoptotic Pathway

